Zidovudine

Zidovudine or azidothymidine is an antiretroviral drug, the first approved for treatment of HIV. It is also sold under the names Retrovir® and Retrovis®, and as an ingredient in Combivir® and Trizivir®. It is an analog of thymidine. (From the Wikpedia article Zidovudine.)

Download PDF

Recent Publications on Zidovudine:
Hepatitis C Virus Coinfection Does Not Affect CD4 Restoration in HIV-Infected Patients after Initiation of Antiretroviral Therapy. Abstract There are conflicting data regarding the influence of hepatitis C...	3rd July, 2008	Wake Forest University Health Sciences, Winston Salem, North Carolina	AIDS Res Hum Retroviruses. 2008 Jul 1;. DOI Direct Link
Phenyl phosphotriester derivatives of AZT: Variations upon the SATE moiety. Synthesis, in vitro anti-HIV activity, stability studies as well as...	1st July, 2008	Institut des Biomolecules Max Mousseron (IBMM), UMR 5247 CNRS - UM 1 & 2,	Bioorg Med Chem. 2008 Jun 18;. DOI Direct Link
Adverse effects of antiretroviral treatment. BACKGROUND: The introduction of highly active antiretroviral therapy...	28th June, 2008	Department of Skin and VD, Medical College and SSG Hospital, Vadodara,	Indian J Dermatol Venereol Leprol. 2008 May-Jun;74(3):234-7.
Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants. OBJECTIVES: Infants infected with HIV-1 perinatally despite single-dose...	27th June, 2008	Department of Paediatrics, University of Oxford, Oxford, UK.	AIDS. 2008 Jul 11;22(11):1333-43. DOI Direct Link
Modelled in vivo HIV fitness under drug selective pressure and estimated genetic barrier towards resistance are predictive for virological response. BACKGROUND: A method has been developed to estimate a fitness landscape...	25th June, 2008	Rega Institute, Katholieke Universiteit Leuven, Leuven, Belgium.	Antivir Ther. 2008;13(3):399-407.
→View more research publications.

BioNews Results for Zidovudine:
Lopinavir/ritonavir Monotherapy or Plus Zidovudine and Lamivudine in Antiretroviral-naive HIV-infected Patient	AIDS:  Jul 2 2008 9:19PM Matching: zidovudine
India's Cipla Gets FDA Nod for Zidovudine Syrup	Therapeutics Daily:  Jul 1 2008 2:00PM Matching: zidovudine
HIV/AIDS Update - Zidovudine Oral Solution USP, 50 mg/5 mL Generic Product Approval	Pharma Live:  Jun 27 2008 8:18PM Matching: zidovudine
Adding Tenofovir (Viread) plus Emtricitabine (Emtriva) to Short-course Zidovudine (Retrovir) and Single-dose N	HIV and Hepatitis.com:  Jun 21 2008 6:06AM Matching: zidovudine
Antiretroviral Therapy in Adults	Journal of the American Medical Association:  Jun 4 2008 11:03PM Matching: zidovudine
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

Zidovudine Clinical Trials:
The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take Zidovudine	HIV Infections
A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients	HIV Infections
Methadone Effects on Zidovudine (ZDV, AZT) Disposition	HIV Infections
A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine	HIV Infections
Evaluation of Patients Who Have Not Had Success With Zidovudine	HIV Infections
→View more trials.

Zidovudine Patents:
US Patent No.	Title
7361760	Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases
7371388	Treatment of Sjogren's syndrome by administration of TR18 polypeptides
7371772	Bicyclic compound, production and use thereof
7371822	Human G-protein coupled receptor variant of HM74, HGPRBMY74
7371837	Human virus causing respiratory tract infection and uses thereof
→View more patents.

Companies working in the area of Zidovudine from Bioportfolio's Biocorporate database :
Company Name
ZHEJIANG WONDERFUL PHARMA & CHEM CO. ZHEJIANG WONDERFUL PHARMA & CHEM CO. are always developing new products exclusively to meet our customers needs of antineoplastic bulk drugs both fine chemicals and plant extracts in close... www.wdfpharm.com/        View full profile

BioPortfolio Ltd. offers e-mail and postal lists for Zidovudine scientists - we have details of around 982 individuals working on Zidovudine .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.